Respiratory & Pulmonary Care

Undiagnosed and Undertreated Sleep Apnea Costs U.S. Employers More Than $180 Billion Annually

George Padron
Cost-Effective Analysis, Real World Evidence, HEOR & Economic Modeling, Respiratory & Pulmonary Care | Mar 14, 2026
A study estimates OSA syndrome costs U.S. employers over $180 billion yearly in productivity losses, making the case for broader screening and CPAP coverage.

High-Dose Flu Vaccine Reduces Cardiovascular Hospitalizations

George Padron
Adult Immunization Programs, Medicare/Medicaid Updates, Cardiovascular Health, Respiratory & Pulmonary Care | Jan 19, 2026
The high-dose influenza vaccine reduces cardiovascular and respiratory hospitalizations in older adults with diabetes compared with the standard-dose vaccine.

Pharmaceutical Manufacturers Commit to Reference-Based Pricing Model for State Programs

Sonia Reyes
Oncology Care, State & Federal Regulations, Medicare/Medicaid Updates, Healthcare Headlines, Policy & Legislation, Respiratory & Pulmonary Care | Dec 20, 2025
Major pharmaceutical manufacturers commit to reference-based pricing aligned with international markets, providing state Medicaid programs access to reduced drug costs.

Respiratory & Pulmonary Care

Undiagnosed and Undertreated Sleep Apnea Costs U.S. Employers More Than $180 Billion Annually

High-Dose Flu Vaccine Reduces Cardiovascular Hospitalizations

Pharmaceutical Manufacturers Commit to Reference-Based Pricing Model for State Programs

Latest News

Dr. Eleonora Teplinsky on ASCO 2026 GLP-1 and Breast Cancer Prevention Data

Study Finds Parkinson's Genetic Yield Varies from 0.4% to 10.7% Based on Ancestry

Merck's Oral PCSK9 Inhibitor Approval Undercuts Injectables

Air Quality Alerts Blanket the Northeast as Canadian Smoke Pushes the AQI Into the Unhealthy Band

Care Partners Often Overlooked Patient Portal Users

Who We Are

Connect